Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Testing remains an important cornerstone of our nation’s fight against COVID-19.
read more
A critical focus for the FDA is preventing and mitigating potential medical product shortages.
read more
Friday, February 08, 2019
The FDA is launching a pilot project in which participants representing the drug supply chain can pilot the use of innovative and emerging approaches for enhanced tracing and verification of prescription drugs in the U.S. to ensure suspect and ...
read more
Monday, November 12, 2018
Manufacturing inspections are one of the FDA’s most important tools for ensuring the quality of pharmaceutical products used by American patients.
read more
Wednesday, February 19, 2020
The FDA plays an essential role in overseeing our Nation’s medical products as part of our vital mission to protect and promote public health, including during public health emergencies.
read more
Update from the FDA on the continued efforts to mitigate the IV saline and amino acids for injection shortages exacerbated by Hurricane Maria.
read more
During COVID-19, FDA will continue to utilize and implement additional alternative inspection tools and approaches while postponing domestic and foreign routine surveillance inspections.
read more
The Truvada (emtricitabine/tenofovir disoproxil fumarate) tablet label was recently updated to expand the indication to include pediatric patients weighing at least 12 kilograms and the addition of the following strength tablets (100/150 mg, 133/200 ...
read more
Wednesday, September 13, 2017
Today, a new and exciting technology – continuous manufacturing (CM) – can truly transform the drug manufacturing process so that it is more reliable and efficient.
read more
The FDA is moving to collect more information on antibiotics used in animals that become meat. It's an effort to stem antibiotic-resistant diseases.
read more
The FDA posted warning letters to four companies who produce homeopathic drug products for significant violations of CGMP.
read more
The FDA is alerting clinical laboratory staff and health care providers of an increased risk of a false positive result with BD SARS-CoV-2 Reagents for the BD Max System test.
read more
The FDA has issued warning letters to three repackers of API for significant violations of current good manufacturing practice (CGMP) requirements.
read more
Tuesday, October 15, 2019
The FDA has posted a warning letter to Torrent Pharmaceuticals in Ahmedabad, Gujarat, India.
read more
The FDA and the EMA are publishing the discussion and main conclusions from a workshop held on November 26, 2018, at the EMA headquarters in London.
read more